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arthroplasty—body temperature is not a
significant risk factor—a prospective,
consecutive, observational cohort study
Michael Dan1,2*, Sara Martinez Martos3, Elaine Beller4, Peter Jones2, Ray Randle3 and David Liu3Abstract
Background: Hypothermia related to anaesthesia and operating theatre environment is associated with increased
blood loss in a number of surgical disciplines, including total hip arthroplasty. The influence of patient temperature
on blood loss in total knee arthroplasty (TKA) has not been previously studied.
Methods: We recorded patient axillary temperature in the peri-operative period, up to 24 h post-operatively, and
analysed the effect on transfusion rate and blood loss from a consecutive cohort of 101 patients undergoing
primary TKA.
Results: No relationship between peri-operative patient temperature and blood loss was found within the recorded
patient temperature range of 34.7–37.8 °C. Multivariable analysis found increasing age, surgical technique, type of
anaesthesia and the use of anti-platelet and anticoagulant medications as significant factors affecting blood loss
following TKA.
Conclusion: Patient temperature within a clinically observed range does not have a significant impact on blood
loss in primary TKA patients. As long as patient temperature is maintained within a reasonable range during the
intra-operative and post-operative periods, strategies other than rigid temperature control above 36.5 °C may be
more effective in reducing blood loss following TKA.
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Blood loss during joint arthroplasty surgery can be sig-
nificant and substantial, rendering the patient at risk of
requiring an allogenic blood transfusion. Recent data has
demonstrated arthroplasty and fracture surgery to ac-
count for 9.8 % of all transfused red blood cell units. It
was the number one reason for transfusion in patients
undergoing surgery, second only to haematology and on-
cology when considering all medical subspecialties [1].
Therefore, every effort should to be made to reduce the* Correspondence: michaeldan@hotmail.com
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during total knee arthroplasty (TKA).
Anaesthetic agents impair the control of body
temperature and in combination with operating room
temperature are largely responsible for the hypothermia
associated with surgery. These agents result in loss of
thermoregulatory controls through reduction of shiver-
ing and vasoconstriction [2–5]. Hypothermia results
from an initial redistribution of heat from the core to
the periphery, followed by ongoing decreased metabolic
heat production and an increased cutaneous skin loss
[6]. Surgical patients without active warming measures
typically undergo a 1–2 °C fall in body temperature.
As a result, hypothermia during surgery theoretically
produces increased blood loss. Hypothermia impairs the
clotting cascade, resulting in increased prothrombin andle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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body temperature also decreases the production of
thromboxane A2, which is responsible for platelet aggre-
gation and activation, as well as vasoconstriction. The
decrease in thromboxane A2 results in increased bleed-
ing times [8, 9].
Whether hypothermia-induced coagulopathy results
in clinically significant increased blood loss remains
controversial. A meta-analysis of studies investigating
hypothermia in different surgical specialties concluded
that mild hypothermia does increase blood loss [10].
Three studies have looked at the effect of hypothermia
and blood loss in total hip arthroplasty, with varied
conclusions. Schmied et al. [11] and Winkler et al. [12]
demonstrated significantly less blood loss in the
warmer patient group, with as little as 0.5–1.5 °C
temperature difference. In contrast, Johansson et al.
[13] found no significant difference between the two
groups with an average 0.8 °C variation in temperature.
A retrospective study showed active warming reduces
transfusion requirements in total hip and knee replace-
ments, but this study failed to demonstrate a change in
haemoglobin levels with treatment [14]. Despite con-
flicting results in the literature, NHMRC guidelines
recommend the use of hypothermia prevention strat-
egies to reduce the incidence of transfusion and blood
loss during surgery.
In order to clarify the impact of patient temperature
on blood loss in TKA, we undertook this study. Our aim
was to determine if peri-operative body temperature af-
fects blood loss during TKA. The study hypothesis is
strict maintenance of patient temperature above 36.5 °C
will lead to a significant reduction in blood loss in pa-
tients undergoing primary TKA.Methods
The study is a prospective, consecutive, observational
cohort of 101 patients undergoing primary TKA between
January and June 2013 by two surgeons in the same ortho-
paedic department. Revision and bilateral procedures were
excluded from the study. Ethics approval was obtained
through the Hospital’s Regional Ethics Committee, and all
patients gave informed consent prior to inclusion in the
study.
A medial parapatellar approach without tourniquet
was used in all patients. One surgeon (surgeon B) used
computer navigation for alignment and preparation, with
cementation of all components in 55 patients. The other
surgeon (surgeon A) employed intramedullary instru-
mentation, with a hybrid prosthesis for the remaining
46 patients. The patella was resurfaced in all patients.
All knees were closed in layers with an intra-articular
drain, which was removed in day 1 post-operatively. Allpatients commenced immediate weight bearing and ac-
tive range of motion from day 1 post-operatively.
Both surgeons used mechanical devices for deep vein
thrombosis (DVT) prophylaxis, together with either riv-
aroxaban 10 mg daily initiated 6 h post operation (sur-
geon A) or enoxaparin 40 mg daily initiated 4 h post
operation (surgeon B). Patients already on coumadin
pre-operatively or with a history of previous pulmonary
emboli continued their coumadin peri-operatively, aim-
ing for a target international normalized ratio (INR) of
2 on the day of surgery. In addition, aspirin (100 mg)
was used in patients deemed high risk for cerebrovas-
cular or cardiovascular complications. The patients on
clopidogrel converted to aspirin 100 mg daily, after
ceasing clopidogrel 5 days pre-operatively.
Patient axillary temperature was recorded at specific
time points during the peri-operative period, including
pre-operatively in the anaesthetic bay, post-operatively
prior to leaving the operating theatre, prior to exiting
the recovery room and then at six hourly intervals for
the first 24 h post-operatively. The patients were divided
into three temperature groups; less than 36 °C, between
36 and 36.5 °C and greater than 36.5 °C.
Blood loss was measured using three methods: (1)
intra-operative blood loss, calculated as the difference
between total suction volume and known irrigation
volume; (2) post-operative blood loss using drain vol-
ume; and (3) total blood loss using the difference between
pre-operative and day 1 post-operative haemoglobin
levels.
Data on other factors believed to affect blood loss was
also collected. These included age, sex, body mass index,
heart rate, blood pressure, type of anaesthesia, operation
time and the use of anticoagulant and anti-platelet medi-
cations [15, 16]. The number of units of allogenic blood
transfused for each patient was recorded. The transfu-
sion trigger was haemoglobin of less than 70 g/L or less
than 100 g/L in patients with symptomatic anaemia or
significant comorbidities [17].
Prior to study commencement, a power calculation was
performed. To achieve 80 % power with 5 % significance
level, 21 patients were required in each temperature group
to detect a clinically significant difference of 8 g/L of
haemoglobin between the low and normal temperature
groups. Given the study was observational, estimation
from previous studies on temperature and blood loss in
THA required at least 100 enrolled patients to achieve
21 patients in the low temperature group. Results were
described using proportions, means and standard devia-
tions. Simple and multivariable linear regression was
used to determine predictors of each of the three mea-
sures of blood loss. Interaction terms were fitted be-
tween significant predictors of the outcomes and the
temperature group variable.
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The patient demographics are summarized in Table 1.
There is no statistically significant difference between
the surgeons in mean age of their patients (68.1 versus
68.5). Surgeon A had 60.1 % male patients, whereas B
had 49.9 % male patients.
The mean operating theatre temperature was 19.6 °C.
The average operative time was 81 min (SD 33 min).
The mean pre-operative haemoglobin was 143 g/L (SD
14). The mean estimated intra-operative blood loss was
128 mL (SD 266). The average post-operative drain vol-
ume was 255 mL (SD 213), with an average haemoglobin
difference from pre-operative to day 1 post-operative of
27.2 g/L (SD 10.5). There was no significant correlation
between each of the three outcome measures of blood
loss, as shown in Fig. 1.
Pre-operatively, patient temperature ranged from 34.3
to 37.2 °C, and post-operatively from 34.7 to 37.8 °C.
The minimum temperature recorded at any time point
was 34.3 °C. Only two patients recorded temperaturesTable 1 Patient demographics, pre- and post-operative findings
Characteristic Statistic
Total number of patients 101
Gender
Male 55 (56.5 %)
Female 46 (45.5 %)
Age mean (SD) 68.6 (9.2)
BMI mean (SD) 30.6 (4.8)
Surgical technique
Surgeon A intramedullary 46 (45.5 %)
Surgeon B computer navigation 55 (56.5 %)
Heart rate mean (SD) 68 (12)
Systolic blood pressure mean (SD) 131 (23)
Anaesthetic
General 7 (6.9 %)
Spinal 2 (2.0 %)
Regional 3 (3.0 %)
General and regional 38 (37.6 %)
General and spinal 1 (1.0 %)
Spinal and regional 37 (36.6 %)
General spinal and regional 13 (12.9 %)
Operative time mean (SD) 81 min (33)
Anticoagulant/antiplatelet medications
Rivaroxaban 40 %
Low-molecular-weight Heparin 38 %
Aspirin 8 %
Warfarin 5 %
Other 9 %below 35 °C in the pre- and post-operative periods. The
mean patient body temperature at each time point was
similar: pre-operative 36.1 °C (SD 0.5), operative 36.1 °C
(SD 0.6) and post-operative 36.3 °C (SD 0.4). We there-
fore used immediate post-operative temperature to as-
sess the effect of body temperature on blood loss. The
patient body temperature was not found to be associated
with increased blood loss for any of the three measure-
ment outcomes of blood loss. The results of patient
temperature on blood loss are summarized in Table 2,
separating each blood loss parameter and temperature
group according to surgeon. Although the surgeon was a
significant predictor of blood loss outcomes, the inter-
action with temperature category was not significant.
Therefore, overall results were used to assess the rela-
tionship between temperature and outcomes.
Both univariable and multivariable analyses were used
to evaluate factors influencing blood loss in our cohort
of TKA patients. The results are outlined in Tables 3
and 4, respectively.
Using intra-operative volume loss as outcome, predic-
tors of blood loss are increased age and surgical tech-
nique. Surgeon B who used computer navigation had on
average 131 mL less blood loss than surgeon A. Each
year of increased age resulted in 10 mL greater blood
loss. Higher pre-operative systolic blood pressure and fe-
male gender appeared to increase blood loss but were
not statistically significant.
Significant univariable predictors of higher drain volume
included surgeon, operative time, type of anaesthesia and
type of anticoagulant medication. Using multivariable re-
gression analysis, patients undergoing TKA under general
combined with regional anaesthesia, spinal plus regional,
or general plus spinal plus regional had significantly less
drain volume blood loss compared to general anaesthesia
alone. The use of low molecular weight heparin, couma-
din, aspirin, or combination of aspirin and low-molecular-
weight heparin resulted in significantly less blood loss
than the use of rivaroxaban. The use of aspirin in addition
to rivaroxaban caused increased blood drainage loss when
compared with rivaroxaban alone.
The two variables predictive of total haemoglobin loss
are surgeon and requirement for allogenic blood transfu-
sion. Surgeon B had on average 4.9 g/L less haemoglobin
loss than surgeon A. The patients who received an allo-
genic blood transfusion had on average 9.3 g/L more
haemoglobin loss.
Discussion
The results of our study failed to demonstrate any effect
of patient temperature during the peri-operative period,
within the range we observed between 34.3 to 37.2 °C,
on blood loss in primary TKA. Measuring blood loss
through intra-operative suction volume, post-operative
Fig. 1 Scatterplot matrix of the three measures of blood loss
Dan et al. Journal of Orthopaedic Surgery and Research  (2015) 10:97 Page 4 of 7drainage and post-operative change in haemoglobin, no
difference could be demonstrated in patients with tem-
peratures below 36 °C compared to patients with a nor-
mal temperature above 36.5 °C. This resulted in no
difference in allogenic transfusion rate between the pa-
tient temperature groups. Therefore, our hypothesis that
maintaining patient temperature at 36.5 °C and above
during TKA will result in reduced blood loss was not
substantiated.
Our study is not suggesting that anaesthesia-induced
hypothermia is inconsequential or that patient temperature
monitoring is unimportant. Maintenance of patient
temperature may have a greater role in countries where
ambient temperatures are usually low. Hypothermia
may also have a significant role in other complications
such as infection following TKA. What we are suggest-
ing is that within the clinically observed temperatureTable 2 Intra-operative and post-operative blood loss by temperatu
Outcome Low temperature
group (<36.0 °C) n = 26
Mean blood volume loss mL (SD) Surgeon A 218 (184)
Surgeon B 130 (179)
Overall 140 (205)
Mean haemoglobin loss g/L (SD) Surgeon A 22.2 (11.8)
Surgeon B 31.1 (10.9)
Overall 26.4 (12.0)
Mean drain volume mL (SD) Surgeon A 51 (69)
Surgeon B 389 (189)
Overall 213 (220)
Surgeon A used intramedullary instrumentation, surgeon B used computer navigati
*p values are for the comparison between (a) low temperature and normal temperarange, using routine patient warming techniques, blood
loss was not affected. Therefore, rigid maintenance of pa-
tient temperature above 36.5 °C through further active
warming techniques may not be necessary in reducing
blood loss in TKA.
Our study design does have a number of weaknesses
and limitations. The study did not include a control
group. We did not feel it would be ethical to
intentionally expose patients to a low temperature situ-
ation, given what is known from other fields of surgery
and current best practice guidelines [17]. We aimed not
to determine the effect of active warming, but rather
look for a correlation between lower body temperature
and blood loss in the primary TKA, which we believe
our observational prospective study allowed us to do.
Secondly, the patient cohort was derived from two sur-
geons with differing surgical technique. However, there category immediately post-operatively
Low normal temperature
group (36.0 °C–36.5 °C) n = 51
Normal temperature
group (>36.5 °C) n = 24
p values*
155 (269) 137 (199) 0.77, 0.93
90 (324) 125 (456)
101 (300) 133 (302)
26.7 (11.1) 24.1 (6.8) 0.39, 0.53
30.9 (10.0) 25.0 (9.7)
28.7 (10.7) 24.5 (7.7)
75 (77) 90 (73) 0.70, 0.48
348 (196) 493 (105)
235 (208) 260 (213)
on
ture groups and (b) low normal temperature and normal temperature groups
Table 3 Univariable analysis of predictors of blood loss following total knee arthroplasty
Intra-operative blood loss (mL) Post-operative drain volume (mL) Change in haemoglobin (g/L)
Predictors Regression coefficient
(95 % CI)
p value Regression coefficient
(95 % CI)
p value Regression coefficient
(95 % CI)
p value
Age 10.4 (2.3–18.6) 0.01 −3.4 (−8.9 to 2.0) 0.22 0.14 (−0.08 to 0.37) 0.21
Female gender 140.5 (−12 to 293) 0.07 93.6 (−2.1 to 189.3) 0.06 −0.001 (−4.3 to 4.3) 0.99
BMI 3.1 (−13.5 to 19.8) 0.7 9.1 (−1.0 to 19.1) 0.08 −0.38 (−0.83 to 0.07) 0.09
Surgeon 220.3 (71.6 to 369.1) 0.004 317 (253 to 382) <0.001 −4.90 (−9.08 to −0.72) 0.02
Heart rate 1.35 (−5.3 to 7.95) 0.7 3.9 (−0.7 to 8.5) 0.10 0.02 (−0.17 to 0.22) 0.81
Systolic BP 3.3 (−0.06 to 6.7) 0.054 −1.0 (−3.8 to 1.7) 0.46 0.06 (−0.03 to 0.16) 0.18
Anaesthetic type
(reference category
is general anaesthetic alone)
Spinal −108.57 (−952 to 734.9) 0.80 −393 (−829 to 44) 0.08 −23 (−62 to 16) 0.24
Regional 45 (−921.28– 1011.28) 0.93 154 (−144 to 452) 0.31 −18 (−15 to 52) 0.46
General + regional −250 (−1161.02 to 661.02) 0.59 −162 (−369 to 46) 0.13 −14 (−34 to 6) 0.17
Spinal + regional −210 (−0.46 to 568.10) 0.57 −210 (−417 to −4) 0.05 −16 (−36 to 4) 0.12
General + spinal + regional −166.11 (−965.67 to 633.45) 0.68 −361 (−622 to −99) 0.01 −25 (−47 to −2) 0.03





Low-molecular-weight heparin −312 (−387 to −237) <0.001 −11 (−22 to 16) 0.06
Warfarin −205 (−378 to −32.6) 0.02 −10 (−33 to 14) 0.41
Aspirin −332 (−505 to −159) <0.001 −6 (−13 to 25) 0.56
Aspirin + Rivaroxaban 97 (−40 to 235) 0.16 17 (−7 to 39) 0.16
Aspirin + LMWH −287 (−414 to −160) <0.001 −1 (−22 to 20) 0.92
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temperature had an effect on blood loss. Both surgeons
used the same operating theatres with identical surgical
environment. The use of multivariable analysis was able
to separate the effects of surgeon technique from other
factors to ensure that the study conclusions remain
valid. Thirdly, the three cohorts of patient temperature
varied by only 0.5–1 °C. Whilst the effect difference is
small, we believe this reflects real clinical practice and
makes the findings applicable to what surgeons would
routinely observe. In addition, previous studies have re-
ported even mild hypothermia (<10 C) significantly in-
creases surgical blood loss by approximately 16 % and
the relative risk of transfusion by 22 % [10]. Fourthly,
our method for determining intra-operative blood loss
may not be the most accurate and reliable approach. We
observed a large standard deviation for intra-operative
blood loss of 389 mL from a mean of 70 mL and in-
cluded some patients with a negative difference. The
method used does not account for blood on the drapes
or blood taken up by surgical sponges. To overcome this
weakness, blood loss was also estimated using two other
methods including post-operative drain volume andchange in haemoglobin. None of the three measures for
blood loss in our study were affected by patient
temperature, so we feel our conclusions are still valid. Fi-
nally, pulmonary artery temperature is considered the
gold standard for temperature measurement. Our study
used axillary temperature as the best non-invasive
method and the most practical technique for daily clin-
ical practice. Axillary temperature has been shown to
compare well with pulmonary artery temperature [18]
and is equivalent to other invasive measures of core
temperature such as intravesical and rectal temperature
[19]. Whilst ideally core temperature would have been a
more accurate method of measurement, we used a con-
sistent reproducible technique for axillary temperature
across the whole patient cohort and therefore feel our
methodology is still justifiable and credible. As we re-
corded temperatures up to 24 h post-operatively, includ-
ing in the recovery room and surgical ward, using
invasive methods was not possible. Our aim was to de-
termine the effect of patient temperature on blood loss
even after departure from the operating room.
In our results, there was no correlation between intra-
operative blood loss, post-operative drain volume and
Table 4 Multivariable analysis of predictors of blood loss following total knee arthroplasty
Intra-operative blood loss (mL)
Predictor Regression coefficient (95 % CI) p value
Age 10.3 (4.8 to 15.9) <0.001
Surgeon B −131 (−235 to −27) 0.01
Drain Volume (mL)
Predictor Regression coefficient (95 % CI) p value
Medication (reference category is rivaroxaban alone) <0.001
Low molecular weight heparin −282 (−360 to −205) <0.001
Warfarin −238 (−406 to −70) 0.01
Aspirin −300 (−464 to −137) <0.001
Aspirin + rivaroxaban 133 (−2 to 267) 0.05
Aspirin + LMWH −232 (−372 to −93) 0.001
Type of anaesthetic
(reference category is general anaesthetic alone)
0.02
Spinal −290 (−621 to 41) 0.09
Regional 24 (−187 to 236) 0.82
General + regional −193 (−341 to −45) 0.01
Spinal + regional −201 (−350 to −51) 0.01
General + spinal + regional −218 (−410 to −26) 0.03
Haemoglobin loss (g/L)
Predictor Regression coefficient (95 % CI) p value
Surgeon B −4.3 (−8.5 to −0.1) 0.04
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extravasation, residual knee blood volume and haemoly-
sis commonly observed following TKA is most likely to
account for this observed variation [20].
Several other factors were highlighted to affect blood
loss during primary TKA in our study. In common with
previous literature, our results demonstrated age, surgi-
cal technique, anaesthetic type and type of anticoagulant
medication used for DVT prophylaxis to impact blood
loss. The exact cause of the age effect is not clear and
cannot be determined from the data collected in our
study. We postulate older patients have higher blood
pressures, combined with reduced arterial tone and ca-
pillary fragility, causing greater intra-operative blood
loss. Although age is a non-modifiable risk factor, it is
important to appreciate its impact and to optimize pre-
operative haemoglobin more diligently in elderly patients
prior to surgery.
There was also a significant difference in blood loss
between the two surgeons. A hybrid prosthesis was used
by surgeon A and fully cemented prostheses by surgeon
B. However blood loss has not been found to be associ-
ated with prosthesis type in terms of fixation in TKA
[21]. We believe the difference in blood loss relates to
instrumentation and type of anticoagulant, with both
factors contributing significantly. Surgeon A usedintramedullary instrumentation whereas surgeon B
used computer-assisted navigation. Computer naviga-
tion has previously been demonstrated to produce
reduced blood loss [22, 23], as a consequence of avoid-
ance of violating the femoral and tibial intramedullary
canals.
Our study reinforces the concept of regional and
spinal anaesthesia having a protective effect against
blood loss and is the first from our review to show a
protective effect in TKA. Regional anaesthesia results in
decreased arterial blood pressure [24], whilst spinal an-
aesthesia leads to venous hypotension and a decreased
venous pressure at the surgical site [25].
Rivaroxaban was shown to be associated with a signifi-
cantly higher drain volume than low-molecular-weight
heparin, aspirin and coumadin. Aspirin in combination
with rivaroxaban increased drain volume over rivaroxa-
ban alone and resulted in the greatest blood loss. Our
study results contrast previous reports showing no sig-
nificant difference between low-molecular-weight hep-
arin and rivaroxaban and may reflect the surgeon effect
on thrombophylactic preference not accounted for by
multivariable analysis [26]. The patients continuing cou-
madin in the peri-operative period with an INR of 2 on
the day of surgery was associated with a lower drain vol-
ume than patients treated with low-molecular-weight
Dan et al. Journal of Orthopaedic Surgery and Research  (2015) 10:97 Page 7 of 7heparin and rivaroxaban. The practice of continuing
coumadin without cessation in patients already taking
the medication pre-operatively or in patients with previ-
ous history of pulmonary emboli was utilized by both
surgeons and supports a growing trend that peri-
operative bridging therapy and coumadin cessation may
not be necessary or the most effective strategy in pa-
tients undergoing TKA [27].
Conclusions
Peri-operative patient temperature, within the clinically
observed range from 34.3 to 37.2 °C, did not affect blood
loss or the need for allogenic blood transfusion in patients
undergoing TKA in our study. Avoiding hypothermia is
an important aspect on peri-operative patient care; how-
ever, rigid temperature control above 36.50 °C may not be
necessary to reduce blood loss in primary TKA and other
factors may be more important including anticoagulant
and anti-platelet medications use, the use of computer
navigation and type of anaesthesia. Routine patient warm-
ing techniques that maintain patient temperatures within
a reasonable range are sufficient to prevent clinically sig-
nificant hypothermia-induced blood loss following TKA.
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